NCT05585112View on ClinicalTrials.gov

Articaine 4% Versus Lidocaine 2% for Local Anesthesia of MIH-affected Maxillary Molars

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

October 17, 2022

Primary Completion Date

December 5, 2022

Study Completion Date

December 25, 2022

Conditions
Molar Incisor Hypomineralisation
Interventions
DRUG

Lidocaine 2%

The child will be injected with lidocaine 2%,after that the treatment will be completed , Pain during injection and treatment will be assessed using the FLACC scale and pain after injection and treatment will be evaluated using the Wong-Baker faces pain rating scale

DRUG

Articaine 4%

The child will be injected with 4% Articaine, after that the treatment will be completed , Pain during injection and treatment will be assessed using the FLACC scale and Wong-Baker faces pain rating scale

Trial Locations (1)

Unknown

Tishreen University, Latakia

All Listed Sponsors
lead

Tishreen University

OTHER